TAOK2 and metabolic dysfunction-associated steatotic liver disease: In contrast, we did not detect any correlation between hepatic TAOK2 abundance and the key histological features of NAFLD in humans and TAOK2 antagonism had no impact on lipid accumulation or oxidative stress in human and mouse hepatocytes.